Erlogem 100/150 Tablets

Generic Name- Erlotinib

Drug Class- Antineoplastic agent

Erlotinib is a tyrosine kinase receptor inhibitor used in the management of some types of non-small cell lung cancer and advanced pancreatic cancer. It acts by selectively and reversibly inhibiting the tyrosine kinase activity of epidermal growth factor receptors which are involved in cancer cell proliferation, apoptosis, angiogenesis, invasions and metastasis.



Erlogem 100/150 (Erlotinib) is a chemotherapeutic agent available in form of tablets for oral administration.